1-2 of 2
Susan McCall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Early Efficacy in an Ongoing Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 30 Gray Involved-Site Radiotherapy for Newly Diagnosed, Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Joachim Yahalom, MD, Heiko Schoder, MD, Philip Caron, MD PhD, Pamela Drullinsky, MD, John F. Gerecitano, MD PhD, Audrey Hamilton, MD, Paul Hamlin, MD, Steven M. Horwitz, MD, Alexandra G. Jacob, BS, Matthew J. Matasar, MD MS, Susan McCall, Alison J Moskowitz, MD, Ariela Noy, Lia Palomba, MD, Carol S Portlock, MD, David J. Straus, MD, Stephanie Verwys, Andrew D. Zelenetz, MD PhD, Zhigang Zhang, PhD, Anas Younes, MD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2014) 124 (21): 3085.
https://doi.org/10.1182/blood.V124.21.3085.3085
Published: 2014
Journal Articles

FDG-PET Adapted Sequential Therapy With Brentuximab Vedotin and Augmented ICE Followed By Autologous Stem Cell Transplant For Relapsed and Refractory Hodgkin Lymphoma

Alison Moskowitz, MD, Heiko Schoder, MD, John F. Gerecitano, MD, PhD, Paul Hamlin, MD, Steven M. Horwitz, MD, Matthew J Matasar, MD, MS, Vahakn S Keskinyan, Susan McCall, Ariela Noy, MD, M. Lia Palomba, MD, Carol S. Portlock, MD, David J Straus, MD, Joachim Yahalom, MD, Anas Younes, MD, Andrew D Zelenetz, MD, PhD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2013) 122 (21): 2099.
https://doi.org/10.1182/blood.V122.21.2099.2099
Published: 2013